Top Sell
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.12 | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | €1.06 | - | - |
| Amarin Corp. ADR | 2 | 1 | 0 | 0 | €0.54 | - | - |
| Uniqure B.V. | 1 | 2 | 0 | 0 | €5.46 | €11.00 | 101.539% |
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €7.11 | €21.44 | 201.354% |
| Coherus Bioscien. | 1 | 2 | 1 | 0 | €1.23 | - | - |
| Agenus Inc. | 4 | 2 | 1 | 0 | €0.41 | €37.02 | 8846.834% |
| Atara Biotherapeutics Inc. | 2 | 2 | 0 | 0 | €0.37 | €3.00 | 716.549% |
| Bristol-Myers Squibb | 7 | 3 | 0 | 1 | €44.30 | €67.64 | 52.701% |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €7.05 | €58.50 | 729.787% |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 0 | €3.22 | €7.31 | 127.384% |
| Cellectar BioSciences Inc. | 5 | 4 | 0 | 0 | €1.98 | €11.09 | 460.182% |
| Bluebird Bio Inc. | 7 | 6 | 3 | 0 | €0.56 | €5.47 | 874.093% |
| Glycomimetics Inc. | 3 | 6 | 0 | 3 | €0.15 | €9.13 | 5909.605% |
| Cara Therapeutics Inc. | 10 | 6 | 0 | 2 | €0.32 | €4.61 | 1357.612% |
| Organovo Holdings Inc. | 0 | 8 | 0 | 0 | €0.54 | - | - |
| Cyclacel Pharmaceuticals Inc. | 2 | 8 | 0 | 0 | €0.22 | €14.66 | 6565.591% |
| Minerva Neurosciences Inc. | 0 | 9 | 0 | 0 | €2.48 | - | - |
| Mirati Therapeutics Inc. | 1 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
| Bellicum Pharmaceuticals Inc. | 0 | 10 | 0 | 0 | €0.064 | - | - |
| Novan Inc | 0 | 20 | 0 | 0 | €0.001 | - | - |
| AEterna Zentaris Inc. | 2 | 22 | 0 | 2 | €1.87 | €8.51 | 355.096% |
| Trevena Inc. | 2 | 23 | 0 | 3 | €0.15 | €6.48 | 4136.601% |
| Evoke Pharma Inc. | 0 | 24 | 0 | 1 | €0.37 | - | - |
| Moleculin Biotech Inc | 3 | 25 | 0 | 2 | €0.41 | €18.42 | 4393.659% |